THOUGHT LEADERSHIP
View Our Latest Clinical Trial Innovation Content

From Compliance to Inspection Steadiness: Rethinking TMF After the 2024 EMA GCP Inspectors Report

From Chatbot to Co-Pilot: Why the Most Important AI in Clinical Trials Is the Kind You Don’t Notice

Ask an Expert TMF Series: Risk Proportionate Oversight That Works

AI in Clinical Trials: From Webinar Insights to Audit-Ready Implementation

Study Startup Best Practices: Kickoff Meeting

Ethris Strengthening Clinical Operations with Trial Interactive

How Protas Revolutionizes Clinical Trials for Common Diseases with 100% Site Adoption of Digital Documentation

Going from Complex eTMF to Confident Regulatory Submission

Mitigating Risk while Realizing Efficiencies - Benefits of a Quality Focused Foundation

Audit-Proof Automation: Releasing AI Features in a Validated State

Beyond Surface-Level: AI Deep Inspection of eTMF Records for Quality & Compliance

MHRA Inspection Insights Part 2: The Metrics That Matter

Surfacing Your CTMS and eTMF Using AI

Clinical Trial Software Built Around You

The Reality of Long-Term System Integrations in Life Sciences

What 2025 Taught Us About Clinical Trial Complexity and What We Are Taking Into 2026

Ask an Expert Office Hours - ICH E6(R3)

Ask an Expert: GlobalLearn (LMS) Site Training

Ask an Expert TMF Office Hours - Culture

Ask an Expert TI Tech Office Hours - Lean Oversight

Auditorías en TMF: Recomendaciones para minimizar hallazgos

Understanding Risk-Based CAPA Under ICH E6(R3)

From Systems to Success: Why Your Tech Partners Must Understand Clinical

MHRA Inspection Insights: ICH E6(R3) and the Next Chapter of Quality